Edition:
United Kingdom

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

14.14USD
19 Oct 2018
Change (% chg)

$0.37 (+2.69%)
Prev Close
$13.77
Open
$13.82
Day's High
$14.39
Day's Low
$13.75
Volume
181,494
Avg. Vol
207,401
52-wk High
$16.82
52-wk Low
$3.82

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.28 December 20 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.86 1.86 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 1.54 4.15 1.00 2.43
Quarter Ending Mar-19 4 1.01 1.03 1.00 --
Year Ending Dec-18 6 6.45 14.11 4.00 5.06
Year Ending Dec-19 6 5.32 21.37 0.00 0.93
Earnings (per share)
Quarter Ending Dec-18 7 -0.28 -0.20 -0.39 -0.23
Quarter Ending Mar-19 4 -0.28 -0.20 -0.36 --
Year Ending Dec-18 7 -1.17 -1.01 -1.39 -0.98
Year Ending Dec-19 7 -1.21 -0.84 -1.48 -1.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.18 1.03 0.15 12.99
Quarter Ending Mar-18 1.68 1.06 0.62 36.92
Quarter Ending Dec-17 0.94 1.03 0.09 9.24
Quarter Ending Sep-17 0.94 1.03 0.08 8.86
Quarter Ending Jun-17 0.94 1.03 0.09 9.55
Earnings (per share)
Quarter Ending Jun-18 -0.32 -0.37 0.05 -14.94
Quarter Ending Mar-18 -0.22 -0.27 0.05 -20.91
Quarter Ending Dec-17 -0.24 -0.29 0.05 -18.71
Quarter Ending Sep-17 -0.24 -0.26 0.02 -7.57
Quarter Ending Jun-17 -0.24 -0.23 0.01 -4.17

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1.54 1.54 1.54 1.54 2.43
Quarter Ending Mar-19 1.01 1.01 1.01 1.01 --
Year Ending Dec-18 6.45 6.45 4.97 5.15 5.06
Year Ending Dec-19 5.32 5.32 1.93 2.11 0.93
Earnings (per share)
Quarter Ending Dec-18 -0.28 -0.28 -0.29 -0.29 -0.23
Quarter Ending Mar-19 -0.28 -0.28 -0.30 -0.30 --
Year Ending Dec-18 -1.17 -1.17 -1.20 -1.20 -0.98
Year Ending Dec-19 -1.21 -1.21 -1.29 -1.29 -1.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 1 0
Earnings
Quarter Ending Dec-18 0 0 1 0
Quarter Ending Mar-19 0 0 1 0
Year Ending Dec-18 0 0 2 0
Year Ending Dec-19 0 0 2 0